{"name":"Guohua Zeng","slug":"guohua-zeng","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFA4MWIwZjJRU3lvWGhBd3NJNngwOWVCS3p4NWZXSGEtRlJEMjEwSTZnQVEyUnRqTy1GOGw5cXZoOEl4T24xQXduSVlTSWkwdWVHZ3pLSU5ZRGgzeGh6Y2NhOTFCUkh4dm5WelIwV3UybnJCNTNTMnZiNXB0WQ?oc=5","date":"2025-08-27","type":"pipeline","source":"Wiley","summary":"Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Mediated by Excessive Drp1 SUMOylation in Diabetic Nephropathy Mice - Wiley","headline":"Asprosin Aggravates Tubular Epithelial Cell Injury and Phenotypic Transformation via Mitochondrial Dynamics Disorder Med","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE1Ma1VJODB6NGtOQ2ZPTHZpMXc2MHlkb281a0RGZDFVdnBvQUVaSWVXbnNFX2Jvdm11cC1xT3hGSF9MUDhZNHBCVXpDMXIwQTcxUUNnYko2djdHSHJHVUxOVThoMA?oc=5","date":"2023-01-24","type":"pipeline","source":"Wiley Online Library","summary":"Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models - Wiley Online Library","headline":"Asprosin aggravates vascular endothelial dysfunction via disturbing mitochondrial dynamics in obesity models","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}